tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Samuel Brodovsky, 22 are a BUY (68.75%), 10 are a HOLD (31.25%).
Analyst Samuel Brodovsky, currently employed at TRUIST, carries an average stock price target met ratio of 71.45% that have a potential upside of 21.78% achieved within 91 days.
Samuel Brodovsky’s has documented 59 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VCEL, Vericel Corp Ord at 18-Dec-2024.
Analyst best performing recommendations are on SIBN (SI-BONE).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) at 1/31/2023. The price target of $29 was fulfilled within 2 days with a profit of $1.53 (5.57%) receiving and performance score of 27.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$24
$5.72 (31.29%)
$25
5 months 29 days ago
(11-Apr-2025)
5/10 (50%)
$2.84 (13.42%)
22
Hold
$72
1 years 8 months 16 days ago
(24-Jan-2024)
2/2 (100%)
$7.84 (12.22%)
200
$52
$33.23 (177.04%)
$61
2 years 8 days ago
(02-Oct-2023)
5/8 (62.5%)
$20.49 (65.03%)
106
Buy
$56
$37.23 (198.35%)
$52
2 years 8 months 10 days ago
(30-Jan-2023)
1/4 (25%)
$8.87 (18.82%)
91
Buy
$60
$41.23 (219.66%)
$70
2 years 11 months 9 days ago
(01-Nov-2022)
2/5 (40%)
$21 (53.85%)
58
What Year was the first public recommendation made by Samuel Brodovsky?
